Yatin Suneja

Stock Analyst at Guggenheim

(4.90)
# 257
Out of 4,382 analysts
391
Total ratings
52.8%
Success rate
26.8%
Average return

Stocks Rated by Yatin Suneja

Zenas BioPharma
Jun 5, 2026
Maintained: Buy
Price Target: $55
Current: $17.47
Upside: +214.83%
Praxis Precision Medicines
Jun 2, 2026
Maintained: Buy
Price Target: $800
Current: $254.00
Upside: +214.96%
ABIVAX Société Anonyme
Jun 2, 2026
Maintained: Buy
Price Target: $175
Current: $101.53
Upside: +72.36%
Oculis Holding AG
Jun 1, 2026
Maintained: Buy
Price Target: $75$45
Current: $11.21
Upside: +301.43%
Immunovant
May 26, 2026
Maintained: Buy
Price Target: $44$62
Current: $31.11
Upside: +99.29%
Roivant Sciences
May 26, 2026
Maintained: Buy
Price Target: $30$36
Current: $28.58
Upside: +25.96%
Cabaletta Bio
May 15, 2026
Reiterated: Buy
Price Target: $16
Current: $3.25
Upside: +392.31%
Alumis
May 15, 2026
Reiterated: Buy
Price Target: $32$34
Current: $19.06
Upside: +78.38%
SAB Biotherapeutics
May 13, 2026
Maintained: Buy
Price Target: $15
Current: $3.38
Upside: +343.79%
Sionna Therapeutics
May 13, 2026
Maintained: Buy
Price Target: $50
Current: $35.37
Upside: +41.36%
Maintained: Buy
Price Target: $14
Current: $1.84
Upside: +660.87%
Reiterated: Buy
Price Target: $1,120$1,135
Current: $891.32
Upside: +27.34%
Maintained: Buy
Price Target: $60
Current: $30.01
Upside: +99.93%
Maintained: Buy
Price Target: $15
Current: $3.40
Upside: +341.18%
Maintained: Buy
Price Target: $14
Current: $1.63
Upside: +758.90%
Maintained: Buy
Price Target: $50
Current: $13.10
Upside: +281.68%
Reiterated: Buy
Price Target: $200
Current: $80.51
Upside: +148.42%
Maintained: Buy
Price Target: $245$260
Current: $232.32
Upside: +11.91%
Reiterated: Buy
Price Target: $51
Current: $16.59
Upside: +207.41%
Maintained: Buy
Price Target: $975$995
Current: $635.45
Upside: +56.58%
Reiterated: Buy
Price Target: $25
Current: $10.13
Upside: +146.79%
Reiterated: Buy
Price Target: $246$260
Current: $195.34
Upside: +33.10%
Maintained: Buy
Price Target: $125$200
Current: $60.14
Upside: +232.56%
Reiterated: Buy
Price Target: $75
Current: $16.53
Upside: +353.72%
Initiated Coverage: Buy
Price Target: $70
Current: $12.77
Upside: +448.16%
Maintained: Buy
Price Target: $128$100
Current: $7.26
Upside: +1,277.41%
Reiterated: Buy
Price Target: $60$90
Current: $51.73
Upside: +73.98%
Reiterated: Buy
Price Target: $140
Current: $50.37
Upside: +177.94%
Reiterated: Buy
Price Target: $90
Current: $28.62
Upside: +214.47%
Maintained: Buy
Price Target: $20
Current: $17.90
Upside: +11.73%
Reiterated: Hold
Price Target: n/a
Current: $34.19
Upside: -
Reiterated: Buy
Price Target: $175
Current: $163.88
Upside: +6.79%
Reiterated: Buy
Price Target: $26
Current: $3.17
Upside: +720.19%
Reiterated: Buy
Price Target: $68
Current: $11.78
Upside: +477.25%
Maintained: Hold
Price Target: $20
Current: $21.56
Upside: n/a
Upgraded: Buy
Price Target: $45
Current: $21.62
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $13.11
Upside: n/a
Maintained: Buy
Price Target: $44$50
Current: $73.65
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $5.95
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $10.55
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $1.11
Upside: n/a
Initiated Coverage: Buy
Price Target: $24
Current: $15.46
Upside: n/a
Reiterated: Buy
Price Target: $9
Current: $2.92
Upside: n/a
Reiterated: Buy
Price Target: $115$123
Current: $28.29
Upside: n/a
Initiated Coverage: Buy
Price Target: $12
Current: $0.7488
Upside: n/a
Reiterated: Buy
Price Target: $21$32
Current: $18.00
Upside: n/a
Rated: Buy
Price Target: n/a
Current: $40.16
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $9.79
Upside: n/a